Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice

AIDS

Volumn 10, Issue 7, 1996, Pages 701-710

  Corallini, Alfredo ^a   Campioni, Diana ^a   Rossi, Cristina ^a   Albini, Adriana ^b   Possati, Laura ^c   Rusnati, Marco ^d   Gazzanelli, Giancarlo ^e   Benelli, Roberto ^b   Masiello, Luciana ^b   Sparacciari, Valentina ^c   Presta, Marco ^d   Mannello, Ferdinando ^e   Fontanini, Gabriella ^f   Barbanti Brodano, Giuseppe ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF URBINO   (Italy)

^f UNIVERSITY OF PISA   (Italy)

Author keywords

Angiogenesis; HIV 1 Tat; Kaposi's sarcoma; Metastases; Proteolytic activity; Transgenic mice

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; GELATINASE; PROTEINASE; TRANSACTIVATOR PROTEIN;

ADENOCARCINOMA; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HEART MUSCLE CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; KIDNEY; LUNG; LYMPH NODE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR PROMOTION;

EID: 9344268250     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199606001-00003     Document Type: Article

References (34)

1. Friedman-Kien AE, Laubenstein LI, Rubenstein P, et al.: Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med 1982, 96:693-700.
2. Roth WK, Brandsetter H, Stürzl M: Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992, 6:895-913.
3. Salahuddin SZ, Nakamura S, Biberfeld P, et al.: Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988, 242:430-433.
4. Ensoli B, Nakamura S, Salahuddin SZ, et al.: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989, 243:223-226.
5. Folkman J, Klagsbrun NM: Angiogenic factors. Science 1987, 235:442-447.
6. Thompson E, Nakamura S, Shima T, et al.: Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cells chemotaxis and invasiveness. Cancer Res 1991, 51:2670-2671.
7. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 344:84-86.
8. Ensoli B, Buonaguro L, Barillari G, et al.: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993, 67:277-287.
9. Barillari G, Buonaguro L, Fiorelli V, et al.: Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implication for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1992, 149:3727-3734.
10. Barillari G, Gendelman R, Gallo RC, Ensoli B: The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RCD amino acid sequence. Proc Natl Acad Sci USA 1993, 90:7941-7945.
11. Albini A, Fontanini G, Masiello L, et al.: Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 1994, 8:1237-1244.
12. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B: Tat, the human immunodeficiency virus type 1 regulatory protein, has angiogenic properties. Proc Natl Acad Sci USA 1995, 92:4838-4842.
13. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G: The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988, 335:606-611.
14. Corallini A, Altavilla G, Pozzi L, et al.: Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993, 53:5569-5575.
15. Vogel J, Hinrichs SH, Napolitano LA, Ngo L, Jay G: Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res 1991, 51:6686-6690.
16. Campioni D, Corallini A, Zauli G, Possati L, Altavilla G, Barbanti-Brodano G: HIV type 1 extracellular Tat protein stimulates growth and protects from apoptosis cells of BK virus/tat transgenic mice. AIDS Res Hum Retroviruses 1995, 11:1039-1048.
17. Zauli G, Gibellini D, Milani D, et al.: Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res 1993, 53:4481-4484.
18. Kleinman HK, McGarvey ML, Hassel JR: Basement membranes complexes with biological activity. Biochemistry 1986, 25:312-318.
19. Wright CM, Felber BK, Paskalis H, Pavlakis GN: Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science 1986, 234:988-992.
20. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982, 2:1044-1051.
21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 277:680-685.
22. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecylsulphate and copolymerised substrates. Anal Biochem 1980, 102:196-202.
23. Meneguzzi G, Chenciner N, Corallini A, Grossi MP, Barbanti-Brodano G, Milanesi G: The arrangement of integrated viral DNA is different in BK virus-transformed mouse and hamster cells. Virology 1981, 111:139-153.
24. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975, 98:503-517.
25. Vecchi A, Garlanda C, Lampugnani MG, et al.: Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Eur J Cell Biol 1994, 63:247-254.
26. Vassalli JD, Belin D: Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 1987, 214:187-191.
27. Thornton SC, Mueller SN, Levine EM: Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983, 222:623-625.
28. Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature 1982, 297:307-312.
29. Albini A, Benelli R, Presta M, et al.: HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene 1996, 12:289-297.
30. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
31. Ensoli B, Gendelman R, Markham P, et al.: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 371:674-680.
32. 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 1992, 89:1557-1561.
33. 1 integrins during human melanoma cell invasion. Cancer Res 1993, 33:3411-3415.
34. Werb Z, Tkemisle L, Behrendtsen O, Crowley E, Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989, 109:877-888.